Skip Navigation


Carcinogenesis Advance Access originally published online on October 17, 2007
Carcinogenesis 2008 29(4):673-680; doi:10.1093/carcin/bgm228
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/4/673    most recent
bgm228v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Imai, K.
Right arrow Articles by Yamamoto, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, K.
Right arrow Articles by Yamamoto, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics

Kohzoh Imai* and Hiroyuki Yamamoto1

Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo 060-8556, Japan
1 First Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo 060-8543, Japan

* To whom correspondence should be addressed. Tel: +81 11 611 2111 ext. 2100; Fax: +81 11 613 3485; Email: imai{at}sapmed.ac.jp Correspondence may also be addressed to Hiroyuki Yamamoto. Tel: +81 11 611 2111 ext. 3211; Fax: +81 11 611 2282; Email: h-yama{at}sapmed.ac.jp

DNA mismatch repair (MMR) deficiency results in a strong mutator phenotype and high-frequency microsatellite instability (MSI-H), which are the hallmarks of tumors arising within Lynch syndrome. MSI-H is characterized by length alterations within simple repeated sequences, microsatellites. Lynch syndrome is primarily due to germline mutations in one of the DNA MMR genes; mainly hMLH1 or hMSH2 and less frequently hMSH6 and rarely hPMS2. Germline hemiallelic methylation of MLH1, termed epimutation, has been reported to be a new cause of Lynch syndrome. MSI-H is also observed in ~15% of colorectal, gastric and endometrial cancers and in lower frequencies in a minority of other tumors, where it is associated with the hypermethylation of the promoter region of hMLH1. MSI-H underlies a distinctive tumorigenic pathway because cancers with MSI-H exhibit many differences in genotype and phenotype relative to cancers without MSI-H, irrespective of their hereditary or sporadic origins. Genetic, epigenetic and transcriptomic differences exist between cancers with and those without the MSI-H. The BRAF V600E mutation is associated with sporadic MSI-H colorectal cancers (CRCs) harboring hMLH1 methylation but not Lynch syndrome-related CRCs. The differences in genotype and phenotype between cancers with and those without MSI-H are likely to be causally linked to their differences in biological and clinical features. Therefore, the diagnosis of MSI-H in cancers is thus considered to be of increasing relevance, because MSI-H is a useful screening marker for identifying patients with Lynch syndrome, a better prognostic factor and could affect the efficacy of chemotherapy. This review addresses recent advances in the field of microsatellite instability research.

Abbreviations: CIMP, CpG island hypermethylator phenotype; CIMP-H, CIMP-high; CIMP-L, CIMP-low; CIN, chromosomal instability; CRC, colorectal cancer; HDAC, histone deacetylase; HNPCC, hereditary non-polyposis colorectal cancer; LOH, loss of heterozygosity; MMR, mismatch repair; MSI, microsatellite instability; MSI-H, high-frequency MSI; MSI-L, low-frequency MSI; MSS, microsatellite stable; NMD, nonsense-mediated decay; 5-FU, 5-fluorouracil

Received May 14, 2007; revised September 8, 2007; accepted October 5, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. M. Woerner, Y. P. Yuan, A. Benner, S. Korff, M. von Knebel Doeberitz, and P. Bork
SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology
Nucleic Acids Res., October 9, 2009; (2009) gkp839v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Wallace, M. V. Grau, D. Ahnen, D. C. Snover, D. J. Robertson, D. Mahnke, J. Gui, E. L. Barry, R. W. Summers, G. McKeown-Eyssen, et al.
The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum
Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2310 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
J. K. TRIANTAFILLIDIS, G. NASIOULAS, and P. A. KOSMIDIS
Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies
Anticancer Res, July 1, 2009; 29(7): 2727 - 2737.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.